A Phase 3 Study of Obexelimab in Patients with IgG4-Related Disease

Authors
Category Primary study
Registry of TrialsClinical Trials Information System
Year 2022
This article has no abstract
Epistemonikos ID: 52362df20246d0d35ef62ad2f4d2396562cac01c
First added on: Mar 21, 2025